Trial · NCT03152552
Participant flow35
How many started, completed or left each group, period by period.
1 to 20 of 35
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period 1 (12 Weeks) | STARTED | LIK066 2.5mg | 15 | |
| Treatment Period 1 (12 Weeks) | STARTED | LIK066 10mg | 16 | |
| Treatment Period 1 (12 Weeks) | STARTED | LIK066 50mg | 31 | |
| Treatment Period 1 (12 Weeks) | STARTED | EMPA 25mg | 30 | |
| Treatment Period 1 (12 Weeks) | STARTED | Placebo | 33 | |
| Treatment Period 1 (12 Weeks) | Full Analysis Set (FAS) | LIK066 2.5mg | 15 | |
| Treatment Period 1 (12 Weeks) | Full Analysis Set (FAS) | LIK066 10mg | 16 | |
| Treatment Period 1 (12 Weeks) | Full Analysis Set (FAS) | LIK066 50mg | 30 | |
| Treatment Period 1 (12 Weeks) | Full Analysis Set (FAS) | EMPA 25mg | 30 | |
| Treatment Period 1 (12 Weeks) | Full Analysis Set (FAS) | Placebo | 33 | |
| Treatment Period 1 (12 Weeks) | COMPLETED | LIK066 2.5mg | 7 | |
| Treatment Period 1 (12 Weeks) | COMPLETED | LIK066 10mg | 5 | |
| Treatment Period 1 (12 Weeks) | COMPLETED | LIK066 50mg | 10 | |
| Treatment Period 1 (12 Weeks) | COMPLETED | EMPA 25mg | 10 | |
| Treatment Period 1 (12 Weeks) | COMPLETED | Placebo | 12 | |
| Treatment Period 1 (12 Weeks) | NOT COMPLETED | LIK066 2.5mg | 8 | |
| Treatment Period 1 (12 Weeks) | NOT COMPLETED | LIK066 10mg | 11 | |
| Treatment Period 1 (12 Weeks) | NOT COMPLETED | LIK066 50mg | 21 | |
| Treatment Period 1 (12 Weeks) | NOT COMPLETED | EMPA 25mg | 20 | |
| Treatment Period 1 (12 Weeks) | NOT COMPLETED | Placebo | 21 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03152552/flow